NIH #5F32AI080086-02
Profiling Epigenetic Biomarkers for the Study and Treatment of Lupus
- Amount
- $55K
- Period
- 2009-09-30 → 2011-09-29
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at STANFORD UNIVERSITY
Cancer Genomics and Diagnostics · Cancer Research
2 total · 0 active
NIH #5F32AI080086-02
Awarded at STANFORD UNIVERSITY
NIH #1F32AI080086-01A1
Awarded at STANFORD UNIVERSITY
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2025-12-11
2025-12-11
Blood · 2025-11-03
Blood · 2025-11-03
Non-invasive Mantle Cell Lymphoma risk stratification by inference of tumor proliferation from cfDNA
Blood · 2025-11-03
Blood · 2025-11-03
Blood · 2025-11-03
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopeniasPreprint
Research Square · 2025-10-21 · 1 citations
2025-08-04
2025-08-04
2025-08-04
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer
Cancer Discovery · 2025-04-29 · 13 citations
An ultrasensitive method for detection of cell-free RNA
Nature · 2025-04-16 · 42 citations
Clonal Hematopoiesis Underlies Prolonged Cytopenias after Anti-BCMA CAR-T Therapy
Transplantation and Cellular Therapy · 2025-02-01 · 1 citations
Determinants of Post-CAR Myeloid Neoplasms Evolving after Lymphoma Therapy
Transplantation and Cellular Therapy · 2025-02-01
Blood · 2024-11-05
Blood · 2024-11-05 · 1 citations
Blood · 2024-11-05 · 6 citations
Non-Invasive Characterization and Early Detection of Post-Transplant Lymphoproliferative Disorders
Blood · 2024-11-05 · 1 citations
Single Institution Analysis of Lymphoma Treatment Related Post-CAR Myeloid Neoplasms
Blood · 2024-11-05 · 1 citations